Confirmed Invited Plenary Speakers

  • Dr. Jeff Mumm, Department of Ophthalmology, The John Hopkins University, USA
    “HTS-ready Degenerative Disease Modeling in Zebrafish”
  • Dr. James Gagnon, School of Biological Science, University of Utah, USA
    “CRISPR lineage tracing in the heart and brain”
  • Dr. Calum MacRae, Brigham and Women’s Hospital & Harvard Medical School, USA
    “Changing the velocity of translation: co-clinical modeling of genotype and phenotype”
  • Dr. Rita Fior, Champalimaud Centre for the Unknown, Portugal
    “Zebrafish Avatars towards personalized cancer treatments”
  • Dr. Koichi Kawakami, Molecular and Developmental Biology, National Institute of Genetics, Japan
    “Transposon-mediated genetic methods in zebrafish and their applications to neuroscience and disease modeling”
  • Dr. Karen Townsend, Torys LLP, Toronto, Canada
    ”Emerging Legal Issues in Precision & Personalized Medicine”
  • Dr. Jordan Shavit, Department of Pediatrics, University of Michigan, USA
    “Using zebrafish to model disorders of coagulation and develop therapeutics”
  • Dr. Harold Burgess, National Institute of Health (NICHD), USA
    “Systematic analysis of brain development and behavior in zebrafish autism models”
  • Dr. Randall Peterson, Pharmacology & Toxicology, College of Pharmacy, University of Utah, USA
    “Systematic behavioral screening links embryonic chemical exposures with adult social deficits”
  • Dr. Yimon Aye, Chemical Biology, Swiss Federal Institute of Technology Lausanne (EPFL), Switzerland
    “Keap-ing up your guard: renewed roles of Keap1 protein in innate immunity”
  • Dr. Ross Cagan, Cell, Developmental & Regenerative Biology, Icahn School of Medicine at Mount Sinai & Senior Editor of Disease Models and Mechanism, USA
    “Wings not fins: A fly-to-bedside approach to personalized cancer therapies”
  • Dr. Sidney Kennedy, Canadian Biomarker Integration Network for Depression (CAN-BIND), UHN & SMH; Dept. of Psychiatry, University of Toronto, Canada
    “Clinical biomarker studies and reverse translation to develop new antidepressant therapies”
  • Dr. Cecilia Moens, Fred Hutchinson Cancer Research Center, University of Washington,USA
    “Using the zebrafish to understand the neurodevelopmental basis of speech and swallowing disorders”
  • Dr. Didier Stainier, Developmental Genetics, International Max Planck Research School for Heart and Lung Research, Germany
    “Cardiac regeneration in zebrafish”
  • Dr. Scott Baraban, Department of Neurological Surgery, University of California San Francisco, USA
    “Precision medicine for epilepsy using zebrafish”
  • Dr. Tugce Balci, Medical Genetics, Schulich School of Medicine & Dentistry, Western University, Ontario, Canada
    “Rare disease gene discovery and modeling with Care4Rare-SOLVE & RDMM: A Canadian framework for precision medicine”
  • Mr. Hira Verma, Co-Founder and Board Chair, K.I.D.S. IQ Project, Toronto, Canada
    “The Rise of Parent-Driven Drug Discovery Efforts and Implications for Researchers and Clinicians”